In these studies, a cellular contamination, based on the sum of CD3+ T cells, CD19+ B cells, and CD56+ NK-cells, of up to 10% of the total infused cells was tolerated well by patients with cutaneous or ocular melanoma. This evidence concerns the gene CD19 and ocular melanoma.